Company Overview and News
Stop missing out on important events!
Atcor Medical Holdings Limited (ASX:ACG) has signed a $1 million contract to supply its SphygmoCor® systems and clinical trial support services to a major international pharmaceutical company.
Atcor Medical Holdings Limited (ASX:ACG) has signed three new contracts worth circa $800,00 to supply its SphygmoCor systems and clinical trial support services.
The halt will remain in place until the opening of trade on Wednesday 16th November 2016, or earlier if an announcement is made to the market.